Kohjin Bio Co., Ltd.
177A.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | ¥8,943,149 | ¥9,871,050 | ¥9,871,050 | ¥11,885,550 |
| - Cash | ¥3,149,267 | ¥1,726,936 | ¥1,462,566 | ¥1,734,488 |
| + Debt | ¥2,386,536 | ¥2,469,695 | ¥2,100,096 | ¥2,228,804 |
| Enterprise Value | ¥8,180,418 | ¥10,613,809 | ¥10,508,580 | ¥12,379,866 |
| Revenue | ¥5,206,287 | ¥4,770,096 | ¥4,742,992 | ¥3,947,089 |
| % Growth | 9.1% | 0.6% | 20.2% | – |
| Gross Profit | ¥2,366,036 | ¥1,881,296 | ¥2,454,182 | ¥2,039,200 |
| % Margin | 45.4% | 39.4% | 51.7% | 51.7% |
| EBITDA | ¥1,406,345 | ¥958,102 | ¥1,444,391 | ¥1,140,061 |
| % Margin | 27% | 20.1% | 30.5% | 28.9% |
| Net Income | ¥794,759 | ¥384,000 | ¥829,790 | ¥587,675 |
| % Margin | 15.3% | 8.1% | 17.5% | 14.9% |
| EPS Diluted | 155.52 | 92.2 | 199.23 | 117.18 |
| % Growth | 68.7% | -53.7% | 70% | – |
| Operating Cash Flow | ¥915,551 | ¥823,681 | ¥461,153 | ¥762,981 |
| Capital Expenditures | -¥887,496 | -¥562,804 | -¥560,719 | -¥203,542 |
| Free Cash Flow | ¥28,055 | ¥260,877 | -¥99,566 | ¥559,439 |